- Home
- EFR vs RCKT Comparison
EFR vs RCKT Comparison
Compare EFR & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFR
- RCKT
- Stock Information
- Founded
- EFR 2003
- RCKT 1999
- Country
- EFR United States
- RCKT United States
- Employees
- EFR N/A
- RCKT N/A
- Industry
- EFR Trusts Except Educational Religious and Charitable
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- EFR Finance
- RCKT Health Care
- Exchange
- EFR Nasdaq
- RCKT Nasdaq
- Market Cap
- EFR 344.0M
- RCKT 328.6M
- IPO Year
- EFR N/A
- RCKT N/A
- Fundamental
- Price
- EFR $11.71
- RCKT $3.28
- Analyst Decision
- EFR
- RCKT Buy
- Analyst Count
- EFR 0
- RCKT 13
- Target Price
- EFR N/A
- RCKT $12.96
- AVG Volume (30 Days)
- EFR 88.6K
- RCKT 6.0M
- Earning Date
- EFR 01-01-0001
- RCKT 08-07-2025
- Dividend Yield
- EFR 9.43%
- RCKT N/A
- EPS Growth
- EFR N/A
- RCKT N/A
- EPS
- EFR 1.69
- RCKT N/A
- Revenue
- EFR N/A
- RCKT N/A
- Revenue This Year
- EFR N/A
- RCKT N/A
- Revenue Next Year
- EFR N/A
- RCKT $108.43
- P/E Ratio
- EFR $7.74
- RCKT N/A
- Revenue Growth
- EFR N/A
- RCKT N/A
- 52 Week Low
- EFR $10.95
- RCKT $2.19
- 52 Week High
- EFR $13.29
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- EFR 43.60
- RCKT 51.17
- Support Level
- EFR $11.64
- RCKT $2.88
- Resistance Level
- EFR $11.79
- RCKT $3.74
- Average True Range (ATR)
- EFR 0.09
- RCKT 0.27
- MACD
- EFR 0.01
- RCKT 0.02
- Stochastic Oscillator
- EFR 60.00
- RCKT 35.43
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.